Levodopa-reduced Mucuna pruriens seed extract shows neuroprotective effects against Parkinson's disease in murine microglia and human neuroblastoma cells, Caenorhabditis elegans, and Drosophila melanogaster

Publication Year: 2018 Authors: Johnson S.L. et al. Study Type: Preclinical — In vitro and invertebrate models PMCID: PMC6164394 | Link: View on PubMed Central

Sep 19, 2026 | 1 min read

Research Gist

This study asked an interesting question: does Mucuna's activity depend entirely on its levodopa content, or do other compounds in the seed contribute? Researchers prepared an extract with the levodopa largely removed and tested it across four model systems — mouse microglia, human neuroblastoma cells, C. elegans and Drosophila. Even with levodopa reduced, the extract showed measurable effects. Oxidative stress markers fell, neuroinflammatory signalling was reduced, and alpha-synuclein aggregation decreased. The findings suggest the whole seed contains additional compounds with biological activity beyond the single well-known molecule.

Key Learnings

  • The extract retained activity even after levodopa content was substantially reduced.
  • Oxidative stress markers decreased across the model systems tested.
  • Neuroinflammatory signalling in microglia was reduced.
  • Alpha-synuclein aggregation was lower in the invertebrate models.
  • Results come from cells and invertebrates — human outcomes were not assessed here.